Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery

Current progress in Structure-Based Rational Drug Design marks a new mindset in drug discovery

Show other versions (1)

The past decade has witnessed a paradigm shift in preclinical drug discovery with structure-based drug design (SBDD) making a comeback while high-throughput screening (HTS) methods have continued to generate disappointing results. There is a deficit of information between identified hits and the man...

Full description

Bibliographic Details
Main Authors: Valère Lounnas, Tina Ritschel, Jan Kelder, Ross McGuire, Robert P Bywater, Nicolas Foloppe
Format: Article
Language:English
Published: Elsevier 2013-02-01
Series:Computational and Structural Biotechnology Journal
Subjects:
Rational drug design
virtual screening
protein kinase
G-protein coupled receptors
ligand binding thermodynamics
Online Access:http://journals.sfu.ca/rncsb/index.php/csbj/article/view/csbj.201302011

Internet

http://journals.sfu.ca/rncsb/index.php/csbj/article/view/csbj.201302011

Similar Items